NEWARK, Del.--()--A complimentary webinar will be presented by ParagonRx on the IOM Report Brief released in May 2012 describing the content of a new report the IOM released in a pre-publication version entitled, Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
“The recommendations from the IOM are consistent with the emerging global expectation that pharmaceutical companies and regulators measure and evaluate the benefits and risks of medications proactively across the product lifecycle”
The presentation, “The Recent IOM Report: The Trend Toward Proactive Benefit-Risk Management Gains Speed” will be the focus of a free webinar which will take place Wednesday, June 13, at 12 noon EDT. The topic is the latest in a series of monthly “Wednesday FoREMS” webinars sponsored by ParagonRx, an inVentiv Health company, pioneering expertise in pharmaceutical safe use.
“The recommendations from the IOM are consistent with the emerging global expectation that pharmaceutical companies and regulators measure and evaluate the benefits and risks of medications proactively across the product lifecycle,” commented Jeff Fetterman, President of ParagonRx and presenter of this webinar.
Highlights of the webinar include:
- Context of the IOM report
- Summary of recommendations
- Implications for risk management professionals and policy in the pharmaceutical industry
More information about registering for the “Wednesday FoREMS” webinar series can be found at www.paragonrx.com/rems-hub/forems/. Webinars are held the second Wednesday of each month at 12 noon EDT.
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
Email 